Yes indeed....You did, in fact, hear our new CEO say that Hemp/cannabis could be a bigger driver in shareholder value than VLN. I just got around to reading the notes from the call to make sure I heard that correctly also. Call was short and sweet....my take is that XXII has done everything that they possibly could have done in order to get these FDA approvals. They are simply at the mercy of the FDA timelines. Afterall, it was XXII’s proprietary VLN cigarettes that was used In ALL smoking cessation trials over the last 7 years and that all #’s from these trials are directly related to the exact same VLN cigarettes the public would have access to. It is almost like XXII is saying “why the hell wouldn't you offer this to the public?”. If and when this PMTA and MTRP get the green light, I’m sure our new leader actually has a few connections in the industry??. Very excited to hear about Hemo/cannabis...Always wondered why we had some incredibly unique patents in this space but seemed like they were literally shelved. I like that the call was tight and succinct. I don’t want pump anymore....I want revenue! Have a great weekend gang....
News 
Market Data 
Discover 
